Cancer cell biology – initiation
C61 – C95
- C61: The Wnt signalling pathway and regulation of breast cancer stem-like cells
- C62: DNA damage induces SUMO modification of BRCA1
- C63: MicroRNAs in childhood rhabdomyosarcoma
- C64: Single nucleotide polymorphism microarray analysis defines a specific genetic fingerprint for well-differentiated cutaneous squamous cell carcinomas
- C65: The ovarian TSG OPCML interacts with the ErbB family of receptor tyrosine kinases, abrogating growth factor-induced autophosphorylation and downstream signaling
- C66: Calcium and ERK1/2 play a critical role in the expression of functional metallothionein isoforms in papillary thyroid cancer cells
- C67: Cell senescence and melanoma progression: immortalization as a late event
- C68: Tumour-suppressive function of Fgfr2b in the skin
- C69: A tale of two Cbls: interplay of c-Cbl and Cbl-b in epidermal growth factor receptor downregulation
- C70: RAD51C facilitates checkpoint signalling by promoting CHK2 phosphorylation
- C71: The role of ATM in the response to low oxygen conditions
- C72: Regulation of the class III PI 3-kinase, hVps34, in cancer cells
- C73: Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis
- C74: p53-dependent cell cycle regulation of NDRG1 phosphorylation in colorectal cancer cells
- C75: Investigating the role of MDM2 in regulation of methylation
- C76: Comprehensive serial analysis of gene expression of the cervical epithelium transcriptome
- C77: The proapoptotic kinases MST1 and MST2 interact with RASSF2 translocating it from the nucleus to the cytoplasm
- C78: The role of RASSF1A signalling in the DNA damage response
- C79: Cellular expression and serum soluble forms of adhesion molecules in myeloid leukemia
- C80: Hypoxia induces a switch from hTR to hTERT dependent regulation of telomerase activity in the Ewing’s sarcoma family of tumour (ESFT) cell lines
- C81: An efficient method for derivation and propagation of glioblastoma cell lines that express markers associated with NG2 lineage
- C82: Mutation analysis of PI3K-AKT pathway genes in anal squamous cell carcinoma and anal intraepithelial neoplasia
- C83: Defects in cell polarity underlie tuberous sclerosis-associated renal cell carcinoma
- C84: Regulation of cell death responses in hypoxia
- C85: S100A8 increases pancreatic and colorectal cancer cell motility and proliferation
- C86: S100A6 binds to annexin 2 and modulates pancreatic cancer cell motility
- C87: The RhoA kinase (ROCK) inhibitor Y27632 and specific novel structural analogues of this compound cause irreversible elimination of transformed NIH3T3 cells from cultures
- C88: KIT and PDGFRα mutations are present in over 80% of very low risk gastrointestinal stromal tumours: analysis of 18 gastrointestinal stromal tumours under 2cm in size
- C89: Germline SDHB mutations and familial renal cell carcinoma
- C90: Activation of PPARγ induces PTEN expression in endometrial cancer cell lines
- C91: Inhibition of ATM mediated DNA repair potentiates the cytotoxicity of DNA damaging ionising radiation in HCC cells
- C92: The effect of thymidine phosphorylase on tumour growth
- C93: Glycolytic phenotype and growth properties preserved in a HIF-1β deficient tumor cell line
- C94: Delta-like 4 Notch ligand promotes tumour progression and mediates tumour resistance to anti-VEGF therapy in vivo
- C95: Development of 3D tumour cell and HUVEC assays for phenotypic assessment of small molecular weight and biologic therapeutics
